Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy A total of 709 phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results